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Abstract
In this paper a new drug carrier, the Light-biovector, is described. These biovectors are composed of a neutral, anionic or
cationic polysaccharidic core surrounded by phospholipids. They can be prepared with high yield and in a nearly pure form
as determined by density analysis on sucrose gradients. These particles showed great stability with no sedimentation being
observed after more than one year of storage. Physicochemical studies carried out with dipalmitoylphosphatidylcholine and
dipalmitoylphosphatidylcholinerdipalmitoylphosphatidylglycerol mixtures showed that in Light-biovectors, the lipids are
organized in bilayer surrounding the polysaccharidic core. In presence of a neutral polysaccharidic core, the gel to liquid
phase transition temperature T of DPPC was only slightly affected as compared to liposomal dispersions of the lipid. Inm
contrast, for cationic and anionic Light-biovectors, the T of the lipids was affected by the electric charge born by them
polysaccharidic core, indicating that electrostatic interactions contribute to the organization of the lipid bilayer in these
systems. It was also found that the association of anionic membrane to anionic polysaccharidic cores and the association of
cationic membrane to cationic polysaccharidic cores was possible. q 1997 Elsevier Science B.V.
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1. Introduction
The therapeutic efficiency of numerous drugs is
limited by their lack of specificity towards a given
cellular target. The major portion of the drug remains
unavailable for the intended therapeutic effect and
increases the chances for undesirable effects. These
shortcomings theoretically can be overcome by the
design of a specific carrier for delivery to the desired
site. Liposomes have been studied as drug carriers for
w xthe delivery in living organisms 1–3 . However,
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these systems are not very stable and their drug
loading capacity depends on the drug and lipid chem-
ical structures. Recently, supramolecular biovectors
 .SMBV , a new family of nanoparticulate drug carri-
ers mimicking low density lipoproteins, have been
w xstudied 4–7 . These acylated SMBV are composed
of a cross-linked natural polysaccharidic particle
which is regioselectively acylated on its surface with
fatty acids to give a peripheral hydrophobic surface
onto which a phospholipid monolayer is adsorbed.
Relatively stable particles and high drug loading ratio
 .unpublished results can be obtained with these new
biovectors. In these particles, when the polysaccha-
ridic core was grafted with short chain fatty acids
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 . C8, C12 , the adsorbed phospholipid monolayer di-
.myristoyl- or dipalmitoyl-phosphatidylcholine dis-
played gel-to-liquid phase transition at a temperature
identical to that of a liposomal dispersion of the lipid,
thus suggesting an absence of energetic coupling
between the phospholipid monolayer and the support-
w xing fatty acid layer 4 .
According to the work performed in our laborato-
ries which showed that acylation of the polysaccha-
ridic particle was not required for its association with
lipids, we developed a new type of biovector made of
non-acylated polysaccharidic particle and phospho-
lipids. These new biovectors, which will be referred
to as Light-bio˝ectors, are currently studied as drug
carriers and evaluated in developing vaccines. These
particles were found to be very effective as protein
carriers, against proteolytic hydrolysis and highly
increase human cell TCD4 proliferation against a
 . w xcytomegalovirus CMV antigen 8 . They were partly
characterized using light scattering multiangle tech-
w xnique 9 . They exist in suspension as spheric micro-
gel nanoparticles and the result indicates that the
association of lipids to these nanoparticles decrease
both inter and intraparticle interactions. In this paper,
we describe the preparation and some of the struc-
tural properties of these novel nanoparticles which
provide unique model systems for investigating poly-
saccharidesrphospholipids interactions. Light-bio-
vectors composed of neutral, cationic and anionic
polysaccharidic particles were prepared, and the phase
properties of the surrounding lipids were studied.
These phase properties depend in particular on the
charges of the polysaccharidic core, indicating that
external charges can affect the molecular packing of
lipids. The occurrence of clear-cut gel to liquid phase
transitions and fluorescence quenching experiments
with non-permeant ions indicate that phospholipids
were organized as bilayers around the polysaccha-
ridic particle.
2. Materials and methods
2.1. Chemicals
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine
 . DPPC was purchased from NOF corporation Hy-
.  .ogo, Japan , 1,6-diphenyl-1,3,5-hexatriene DPH , 5-
w x .  .4,6-dichlorotriazin-2-yl amino fluorescein DTAF ,
stearylamine, 1,2-dipalmitoyl-sn-glycero-3-phos-
 .phoglycerol DPPG and phosphate buffered saline
 . PBS were obtained from Sigma Saint Louis, Mo,
. w wUSA . 1-Acyl-2- 12- 7-nitro-2-1,3-benzoxadiazol-4-
. x xyl amino dodecanoyl -sn-glycero-3-phosphocholine
 .NBD-PC was purchased from Avanti polar lipids
 .Alabaster, AL, USA . 1-Chloro-2,3-epoxypropan
 .epichlorydrin and glycidyltrimethylammonium
 .chloride hydroxycholine were obtained from Fluka
 .Saint Quentin Fallavier, France . Phosphoryl chlo-
 .ride was obtained from Prolabo Paris, France .
 .  .Cobalt II chloride CoCl and other salts were of2
analytical grade.
2.2. Preparation of Light-bio˝ectors
Polysaccharidic particles were prepared from U.S.
Pharmacopoeia maltodextrin Glucidex, Roquette,
. w xLille, France as described previously 5,6,8,10 .
Briefly, 100 g of maltodextrin were dissolved in 2 N
sodium hydroxide under magnetic stirring at room
temperature. Addition to the crude mixture of 1-
 .  .chloro-2,3-epoxypropan epichlorydrin 4.72 ml , or
 .of a mixture of epichlorydrin 4.72 ml and gly-
 .cidyltrimethylammonium chloride hydroxycholine
 .  .31.18 g , or of phosphoryl chloride 28.46 ml
yielded neutral, cationic and anionic polysaccharidic
gels, respectively. Then, the gels were neutralized
with acetic acid and finally sheared under high pres-
sure in a Minilab homogeniser Rannie, APV Baker,
.Evreux, France . The neutral, cationic and anionic
polysaccharidic nanoparticles obtained were ultrafil-
trated on a SGI Hi-Flow system 30UFIBr1 S.6r40
.  .kD Setric Genie Industriel, Toulouse, France in´
order to remove low molecular reagents and salts.
Light-biovectors were prepared in a Minilab ho-
mogenizer by the mixing of polysaccharidic nanopar-
ticles and phospholipids at a temperature above the
gel-to-liquid phase transition temperature of the phos-
w xpholipid 11 . Polysaccharide and phospholipid con-
centrations were 1.0 mgrml and 0.2 mgrml, respec-
tively. Phospholipid concentration was determined
w xusing the method of Bartlett 12 for liposomes, non
ionic Light-biovectors and cationic Light-biovectors.
Additionally, an enzymatic colorimetric test
 .PLrMRP2 from Boehrringer Mannheim, Germany
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was used for anionic Light-biovectors. Polysaccha-
ride concentration was determined using the method
w xof Dubois 13 .
(2.3. Preparation of liposomes small unilamellar
)˝esicles
Liposomes were prepared by the injection of an
ethanolic solution of lipids in water as described in
w x w x14,15 and then homogenized 11 . All the samples
prepared were stored in sterile tubes after filtration
through a 0.2 mm filter.
2.4. Size determination of nanoparticles
The mean diameter of polysaccharidic particles,
liposomes and Light-biovectors was determined by
LASER light scattering with the N4MD Coulter
nanoparticle analyzer Coultronics, Margency,
.France . Measurements on dilute samples in 50 mM
PBS were carried out in triplicate at a temperature of
258C.
2.5. Fluorescence labelling of Light-bio˝ectors
Labelling of the polysaccharidic core with fluores-
cein was achieved by adding 10 mg of a DTAF water
 .solution 2 mgrml to 100 mg of polysaccharidic
w xparticles at pH 10, with magnetic stirring 16 . These
labelled particles were washed and purified by ultra-
filtra tio n o n a S G I H I-F lo w sy stem
 .30UFIBr1S.6r40KD with 1 M NaCl and then
subsequently with demineralized water until no fluo-
rescein was detected in the filtrate. The fluorescein-
 .labelled polysaccharidic particles 1 mgrml were
stored in sterile tubes after filtration through a 0.2
mm filter.
The labelling of phospholipid bilayers with DPH
 y3was achieved by adding the probe 10 M in tetra-
.hydrofuran to water suspension of Light-biovectors
or liposomes. Temperature was kept at 608C for 30
w xmin 17 . The final DPH concentration with respect to
the lipids was 0.5 mol%.
For double labelling of Light-biovectors with fluo-
rescein and DPH, Light-biovectors were prepared
with fluorescein-labelled polysaccharidic particles and
the surrounding lipid bilayer was then labelled with
DPH as described above.
All fluorescent Light-biovector and liposome
preparations were kept in the dark.
2.6. Fluorescence spectroscopy
Fluorescence excitation and emission spectra were
recorded with a SLM-Aminco Spectrofluorimeter,
Model 500. In these experiments, and in the fluores-
cence polarization experiments described below, ab-
sorbance of Light-biovector and liposome suspen-
sions recorded with the Hewlett Packard 8452A
.Diode Array Spectrophotometer was never greater
than 0.1. For the fluorescence emission spectra, the
excitation wavelength l was 360 nm for DPH andex
490 nm for fluorescein. For the fluorescence excita-
tion spectra, the emission wavelength l was 426em
nm for DPH and 522 nm for fluorescein.
2.7. Fluorescence polarization
Experiments were performed with a T-format auto-
w xmatic apparatus of our fabrication 4 connected to a
microcomputer. Briefly, the detection system com-
prised two independent channels, one measuring the
vertical component I and the other measuring theV
horizontal component I of the fluorescence emis-H
sion simultaneously. The excitation channel consisted
of a mercury light source, a shutter, a monochro-
 .mator, a rotating polarizer Glan prism polarizing the
incident light alternatively either vertically fluores-
. cence polarization measurement or horizontally de-
termination of the relative sensitivity of the two
.detection systems . Cut-off and band-pass filters were
interposed on the emission beam to eliminate the
excitation light. Samples were placed in a closed,
thermostated housing system and the temperature was
monitored from 08C to 608C by a Peltier element.
When using DPH, the fluorescence emission was
measured over the wavelength range 400–500 nm.
 . Polarization p is calculated as ps I y I r I qV H V
.I .H
2.8. Fluorescence quenching experiments
Light-biovectors and liposomes were prepared with
 .DPPC mixed with NBD-PC 2 mol% , and dispersed
in 1.5 M NaCl. Sample preparation and analysis were
performed extemporaneously to avoid any significant
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and differential penetration of the cobalt quencher
ions in the lipid bilayer with time. In a quartz cuvette,
aliquots of Light-biovector or liposome suspensions
 .were placed phospholipid concentration: 27.2 mM
and fluorescence was measured to find the F value.0
 .Then, CoCl quenching solution 0.3 M in water2
was added to obtain the desired quencher concentra-
tion. Reactants were mixed for 15 s and fluorescence
was measured immediately to obtain the F value.1
As many Light-biovectors or liposomes samples were
used as the number of cobalt ion concentration tested.
The quenching efficiency was calculated as 1y
.F rF =100. Excitation and emission wavelengths1 0
were 474 nm and 535 nm, respectively and tempera-
ture was 208C.
2.9. Isopycnic separation on sucrose gradients
Sucrose gradients were prepared by thawing 9 ml
 .of 20% wrw sucrose solution in 84=19 mm
polyallomer Beckmann tubes, at room temperature. 1
ml of the desired sample liposomes, or polysaccha-
ridic particles, or crude Light-biovectors prepara-
.tions was deposited at the top of the tube and
 .centrifugation 250 000=g, 4 h, 88C was performed
 .in a Beckmann ultracentrifuge Model L5-65
equipped with a SW 41 rotor. After centrifugation,
0.5 ml fractions were collected from top to bottom
with a Gilson automatic micropipet and analyzed by
fluorescence spectroscopy.
3. Results
3.1. Association of polysaccharidic particles with
phospholipids
The degree of association between polysaccharidic
particles and phospholipids was analyzed by separat-
ing the various components on sucrose gradient. Flu-
orescein and DPH, which display distinct fluores-
cence spectra, were used to label polysaccharidic
particles and the lipid bilayers, respectively. Control
experiments showed that the excitation and emission
spectra of both probes were not affected by sucrose.
Four hours ultracentrifugation was the minimum time
required for the sedimentation of lipid-free particles,
liposomes and Light-biovectors to reach equilibrium.
Note that measured fluorescence intensities were
much larger for fluorescein than for DPH. For the
sake of clarity, fluorescein and DPH fluorescence
intensities shown in Fig. 1 were normalized with
respect to their maximum values.
As can be seen in Fig. 1A, lipid-free polysaccha-
 .ridic particles 1 mg of particlesrml sedimented
over a wide sucrose concentration range of 2–20%
with a maximum around 7%, indicating a certain
polydispersity in density of these particles. Lipo-
 .somes 0.2 mg DPPCrml displayed greater density
and narrower polydispersity than polysaccharidic par-
ticles with an isopycnic band around 18–20% su-
crose.
As shown in Fig. 1B, Light-biovectors 0.2 mg
DPPC for 1 mg cationic polysaccharidic
.particlesrml , labelled with fluorescein and DPH,
Fig. 1. Separation of polysaccharidic particles, liposomes and
 .  .Light-biovectors on sucrose density gradients 0–35% . A Sep-
 .aration of fluorescein-labelled polysaccharidic particles ‘ and
 .  .DPH-labelled DPPC liposomes e . B Separation of Light-bio-
vectors whose the polysaccharidic core was labelled with fluores-
 .  .cein v and the DPPC layer with DPH l . Fluorescein and
DPH fluorescence intensities were normalized with respect to
their maximum values.
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were found at 14–19% sucrose concentration with
the two probes, indicating that a large part of the
polysaccharidic particles and lipids cosedimented. It
is worth noting that the association between polysac-
charidic cores and lipids resulted in increased density
and a decreased polydispersity, with a final density
for the Light-biovectors around 17% sucrose, close to
that of liposomes. The fluorescence observed at low
 .sucrose concentration 2–10% probably corresponds
to the presence of free fluorescein in the water phase
and of a few light and lipid-free polysaccharidic
particles. Traces of free fluorescein remained after
purification of labelled polysaccharidic particles.
Control experiments with a solution of free fluores-
cein showed that it spread over 0–7% sucrose. The
small shoulder detected at 19% sucrose may corre-
spond to the presence of denser Light-biovectors or
of small amounts of liposomes. Control experiments
showed that for up to 1 mg DPPC for 1 mg cationic
polysaccharidic particles, homogeneous preparations
of Light-biovectors were obtained, giving a single
and well defined band on sucrose gradient, compara-
ble to that shown in Fig. 1B. For higher DPPCrpoly-
saccharidic particles ratio, Light-biovector prepara-
tions became non homogeneous with the appearance
of a new band corresponding to the presence of free
liposomes. Accordingly, mixtures of DPPC cationic
Light-biovectors and DPPC liposomes, both labelled
with DPH, yielded two well separated bands after
centrifugation on sucrose gradient, indicating no
 .overlap in density of the two entities data not shown.
In summary, this technique shows that Light-bio-
vectors obtained were mainly composed of polysac-
charidic particles associated with lipids.
3.2. Size determination of particles
Lipid-free polysaccharidic particles were relatively
homogeneous in diameter A single particle popula-
tion was detected in the nanosizer, around 35–42 nm
for the neutral and anionic particles and around 75
 .nm for the cationic ones Table 1 .
Lipids alone gave relatively monodispersed liposo-
mal suspensions with a mean diameter depending on
lipidic composition: ;40 nm and ;20 nm for
DPPC and DPPCrDPPG mixtures, respectively Ta-
.ble 1 .
In mixtures of cationic polysaccharidic particles
Table 1
Mean diameter of nanoparticles as measured by LASER light
scattering
Sample Polysaccharidic Mean
core diameter
 .nm
Polysaccharidic particles Neutral 42.3"26
Cationic 74.7"29
Anionic 34.6"13
DPPC liposomes 39.4"13
DPPCrDPPG liposomes 18.5" 9
DPPC Light-biovectors Neutral 39.2" 9
Cationic 82.9"26
Anionic 46.6"18
DPPCrDPPG Light-biovectors Neutral 40.7"17
Cationic 88.6"12
Anionic 45.4"26
Phospholipid concentration was 0.2 mgrml and polysaccharide
concentration was 1 mgrml. Samples were diluted in 50 mM
PBS. Data represent means"S.E. for 10 determinations.
 . ;75 nm in diameter and DPPC liposomes ;40
.nm in diameter at concentrations equivalent to those
found in Light-biovectors, the two populations were
clearly differentiated by the nanosizer analysis. Sur-
prisingly, simple mixtures of cationic polysaccharidic
 .particles and anionic DPPCrDPPG 95r5 wrw li-
posomes tended to precipitate, preventing size mea-
surement of particles. In contrast, Light-biovector
preparations exhibited a single population with a
mean diameter similar to that of the corresponding
lipid-free polysaccharidic particle. This strongly sug-
gests that polysaccharidic core was coated with a thin
phospholipid layer and not with a large multi-layered
system or with adsorbed liposomes.
3.3. Stability of Light-bio˝ectors
We measured at various intervals the diameter of
DPPC liposomal dispersions and Light-biovector
preparations stored at 48C or at room temperature. As
can be seen in Table 2, no significant change in
diameter was detected for cationic and anionic
Light-biovectors stored at 48C for up to one year.
Similar results were obtained with Light-biovectors
 .prepared with a 95r5 wrw DPPCrDPPG mixture
 .data not shown . In contrast, DPPC liposomes
showed aggregation after 3 months at room tempera-
ture, or 6 months at 48C.
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Table 2
Effect of storage on the diameter of various nanoparticle preparations
 .Sample Mean diameter of particles nm
24 h 1 month 3 months 6 months 9 months 12 months
DPPC liposomes
48C 39.4"13 39.1"15 40.6"17 42.4" 9 A A
Room temperature 39.4"13 40.9"11 38.8" 8 A A A
DPPC cationic Light-bio˝ectors
48C 82.9"26 86.2"21 81.2"19 88.7"23 83.9"14 87.4"20
Room temperature 82.9"26 79.5"21 82.2"18 86.1"23 A A
DPPC anionic Light-bio˝ectors
48C 46.6"18 40.3"11 49.9"23 45.1"12 45.2"19 47.0"13
Room temperature 46.6"18 48.0"15 49.2"16 48.1"13 48.5"17 49.4"15
A: aggregated. Samples were stored at room temperature or at 48C. Data represent means"S.E. for 10 determinations.
3.4. Influence of the polysaccharidic core on the lipid
shell.
The phase behavior of the lipid shell surrounding
the polysaccharidic cores was studied by measuring
the gel to liquid phase transition temperature, T , ofm
the lipid. In this study, the influence of charges born
by the polysaccharidic core and the lipids for various
ionic concentrations in the aqueous phase were exam-
ined. T was determined by the fluorescence depolar-m
ization of the probe DPH inserted in the lipid phase
w x18 .
Fig. 2A shows a typical p versus temperature
curve for DPPC liposomes, which accounts for a
clear-cut gel to liquid phase transition with a Tm
w xvalue of 40.58C, as expected for this lipid 18 . Well
defined and cooperative gel to liquid phase transition
was also observed for DPPC associated with Light-
biovectors. As shown in Table 3, T was found overm
the range 39–488C, depending on the nature of the
polysaccharidic core and of the lipids. Generally, in
water and for particles coated with DPPC and
DPPCrDPPG, a neutral polysaccharidic core only
slightly affected T as compared to liposomes. Inm
contrast, T slightly decreased in the presence ofm
cationic polysaccharidic cores and markedly in-
creased with anionic cores. For DPPCrstearylamine
samples, T increased in the presence of cationic andm
anionic cores.
Addition of PBS to Light-biovector suspensions
decreased T , with a more pronounced effect on them
anionic than on the cationic and neutral Light-biovec-
tors.
All these observations clearly indicate that in
Light-biovectors, the membrane is a well organized
lipid bilayer whose phase properties depend partly on
the sign of the charges born by the polysaccharidic
core and the lipid and on the presence of salts in the
water phase.
Fig. 2. Influence of temperature on the fluorescence polarization
 .  .  .p of DPH. A In DPPC liposomes e . B In DPPC associated
 .with neutral polysaccharidic core ‘ , with cationic polysaccha-
 .  .ridic core [ or with anionic polysaccharidic core v .
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3.5. Number of lipid bilayers around the polysaccha-
ridic core
Finally, it was important to determine whether the
polysaccharidic core of Light-biovectors was sur-
rounded by one or several lipid bilayers. Fluores-
cence quenching experiments were carried out using
the probe NBD-PC in which the NBD group has been
shown to be located in the glycerophosphate region
w xof the lipid bilayer 19–21 . Cobalt ions were used as
w x 2qquenchers 21 . Because relatively high Co ion
 .concentrations are required up to 30 mM to achieve
a nearly complete fluorescence quenching of the NBD
group, Light-biovectors were prepared in the pres-
ence of 1.5 M NaCl, in order to avoid important
changes in ion concentrations upon addition of the
quencher to the aqueous phase. Because Co2q ions
are slightly permeant with time through lipid bilayers,
experiments were carried out extemporaneously. To
each sample, Co2q ions were added to the desired
concentration and fluorescence was measured imme-
diately. Superimposable fluorescence quenching
curves were obtained for anionic and cationic Light-
biovectors and unilamellar DPPC liposomes. For the
sake of clarity, only the data obtained for unilamellar
DPPC liposomes and DPPC anionic Light-biovectors
Table 3
Gel to liquid phase transition temperature T of DPPC,m
 .DPPCrDPPG and DPPCrstearylamine DPPCrSA liposomes,
or neutral, cationic and anionic Light-biovectors
 .Lipid Sample T 8Cm
Water PBS
DPPC Liposomes 40.0"0.2 39.2"0.3
Neutral Light-biovector 40.8"0.2 39.8"0.1
Cationic Light-biovector 39.3"0.3 38.4"0.2
Anionic Light-biovector 42.8"0.2 39.0"0.2
DPPCrDPPG Liposomes 41.1"0.1 38.3"0.2
 .95r5, wrw
Neutral Light-biovector 41.0"0.1 39.9"0.5
Cationic Light-biovector 39.3"0.3 39.9"0.2
Anionic Light-biovector 44.8"0.3 39.1"0.2
DPPCrSA Liposomes 43.4"0.1 42.8"0.1
 .95r5, wrw
Neutral Light-biovector nd nd
Cationic Light-biovector 44.9"0.2 43.4"0.1
Anionic Light-biovector 48.5"0.1 44.3"0.2
nd: not determined. Experiments were carried out in water or 100
mM PBS. Data represent means"S.E. for six determinations.
Fig. 3. Influence of Cobalt ions on the fluorescence of the probe
 .  .NBD-PC inserted 2 mol% in DPPC liposomes e and DPPC
 .Light-biovectors v . Lipid concentration was 27.2 mM and
temperature was 208C.
is shown in Fig. 3. In both cases, changes in slope
were detected with 50–55% quenching. Remember-
ing that probe molecules located in the external lipid
layer are affected first, a simple calculation using a
bilayer thickness of 5.5 nm and a molecular area of
2 w x0.47 nm for DPPC in the gel phase 22 , indicates
that for unilamellar vesicles of 40 nm and 80 nm in
diameter, about 65% and 55% of the lipid molecules
are present in the external layer, respectively. This
and the great similarity between the two curves sug-
gests that, like unilamellar DPPC liposomes, Light-
biovectors were composed of a single lipid bilayer.
4. Discussion
The above results clearly indicate that Light-bio-
vectors are mainly composed of a polysaccharidic
core surrounded by a single phospholipid bilayer.
These nanoparticles are monodispersed and homoge-
neous in diameter population. They are reproducible
in diameter and structure and are very stable. This
presents a great advantage in the view for developing
new drug carriers.
From the physicochemical point of view, one can
assume that sugar–phospholipid interactions con-
tribute to the ease of formation of these particles and
their stability. Mono, oligo and polysaccharides have
been described as structural and functionnal mem-
w xbrane-stabilizing factors 23–25 . Sugars and their
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derivatives can be used as cryoprotectives to maintain
w xthe stability of liposomes 24–29 or the functional
integrity and activity of natural membranes after des-
w xiccation or lyophilisation 30 . These molecules not
only bind and entrap water molecules but they also
w xinteract with phospholipids 27–29,31–33 . These in-
teractions depend on the nature of the sugar residues
and phospholipid headgroups and they occur without
the penetration of the sugar residues within the mem-
w xbrane 33 . More than likely, these interactions are
stabilized by a complex network of hydrogen bonds
w xbetween water, sugars and phospholipids 24,25,29 .
In addition, these interactions are reinforced when the
w xmolecular weight of polysaccharides is increased 34 .
In the present study, reticulation of maltodextrin re-
sulted in a very high molecular weight polysaccha-
ridic polymer. This may explain relatively stable
profile of the Light-biovectors.
It is also noticeable that stable Light-biovectors
could be obtained over a relatively wide phospholipid
to polysaccharide concentration range from 0.2 mg
up to 1 mg DPPC for 1 mg cationic polysaccharidic
.particles . However in all cases, Light-biovectors ap-
peared denser and therefore more compact than the
lipid-free polysaccharidic particles. This strongly sug-
gests a certain flexibility of the polysaccharidic chain
enabling the formation of particles surrounded by a
single lipid bilayer with a good adaptation in size of
the polymeric core to the available number of phos-
pholipid molecules.
Mono- and disaccharides have been reported to
increase the gel to liquid phase transition temperature
T of phosphatidylcholines. Osmotic dehydration ofm
the phosphocholine headgroups resulting in a de-
crease of the lipid molecular area and therefore an
increase in the acyl chain order may account for this
w xobservation 24 . Our results clearly show that the
phospholipid bilayer associated with the polysaccha-
ridic core in the Light-biovectors displayed a degree
of cooperativity and organization similar to that of
liposomal structures. The T of DPPC was alsom
affected by its interactions with the polysaccharidic
core, but now with a clear dependence on the charge
born by the polymer. Thus, the T of DPPC inm
neutral Light-biovectors was comparable to that of
liposomes while it slightly decreased for cationic and
increased for anionic Light-biovectors. In anionic
Light-biovectors, incorporation of stearylamine in
DPPC further increased T up to the rather highm
value of ;488C. A possible explanation is in the
orientation of the phosphocholine dipole in response
to the nature and location of charges born by the
polysaccharidic core and the lipids. This dipole has
been shown to behave like a ‘sensor’ of electric
w xcharges in membranes 35 . In phosphatidylcholine
bilayers, the mean orientation of the phosphocholine
moiety is approximately parallel to the membrane
surface. Addition of a cationic amphiphile to the lipid
has been shown to provoke a repulsion of the posi-
tively charged Nq end of the choline residue which
moves outward the membrane while an anionic am-
phiphile has the opposite effect, forcing the Nq end
w xtoward the membrane interior 36 .
In DPPC Light-biovectors, the electric charges are
born by the polysaccharidic core and therefore are
located outside the membrane. Consequently, oppo-
site effects are expected, the negative charges being
attractive for the Nq end and the positive charges
being repulsive. Tilting of the phosphocholine moiety
outward or inward the membrane would lead to an
increase or a decrease in the molecular packing of the
lipids and thus an increase or a decrease in T as wasm
observed for anionic and cationic Light-biovectors,
respectively. In anionic Light-biovectors, addition of
stearylamine to DPPC would reinforce the influence
of the polysaccharidic core, thus explaining the high
T value of 488C found in this case. The fact thatm
these differences in T values between neutral,m
cationic and anionic Light-biovectors nearly disap-
peared when the ionic strength of the water phase
was increased provides support to the idea that the
electric charges born by the polysaccharidic core
contribute to the organization of the surrounding lipid
bilayer.
To conclude, Light-biovectors constitute a new
class of nanoparticles in which the external lipid
layer is stabilized by its interactions with the internal
polysaccharidic core. The data presented reinforces
the concept that sugars and their derivatives can
contribute to the stabilization of membrane structures
and show that these new biovectors provide an inter-
esting system for investigating polysaccha-
riderphospholipid interactions. Incorporation of pro-
teins in Light-biovectors is currently under investiga-
tion in our laboratories: either intrinsic proteins bound
to lipids through hydrophobic interactions or soluble
( )M. Major et al.rBiochimica et Biophysica Acta 1327 1997 32–4040
proteins bound to the polysaccharidic core through
electrostatic interactions.
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